Z-His-OBzl 是一种组氨酸衍生物,可介导Mn2+的配位共组装,形成基于肽的光敏纳米药物。
Cas No.:20794-07-4
Sample solution is provided at 25 µL, 10mM.
Z-His-OBzl is a derivative of histidine (His) and can mediate the coordination of Mn2+ co-assembly to form peptide-based photosensitive nanomedicines[1]. Z-His-OBzl acts as the template amino acid derivative to induce near-infrared (NIR) cyanine dye indocyanine green (ICG) co-assembly due to the amphiphilic and positively charged nature [2]. Z-His-OBzl regulates the self-assembly of phthalocyanine tetrasulfonic acid (Pc) into nanoparticles without vesicle structures, exhibiting fluorescence quenching in solution [3]. Z-His-OBzl can be combined with the endogenous biological pigment biliverdin (BV) to prepare nanoparticles with wide near-infrared absorption, which act as photoacoustic imaging (PAI) contrast agents for diagnosing tumors with high spatial resolution and penetration depth[4].
References:
[1] Li S, van Hest J C M, Xing R, et al. Peptide self-assembly meets photodynamic therapy: from molecular design to antitumor applications[J]. Chemical Communications, 2025, 61(73): 13841-13851.
[2] Li S, Chang R, Zhao L, et al. Two-photon nanoprobes based on bioorganic nanoarchitectonics with a photo-oxidation enhanced emission mechanism[J]. Nature Communications, 2023, 14(1): 5227.
[3] Han J, Liu K, Chang R, et al. Photooxidase‐mimicking nanovesicles with superior photocatalytic activity and stability based on amphiphilic amino acid and phthalocyanine co‐assembly[J]. Angewandte Chemie, 2019, 131(7): 2022-2026.
[4] Chang R, Zhao L, Xing R, et al. Functional chromopeptide nanoarchitectonics: molecular design, self-assembly and biological applications[J]. Chemical Society Reviews, 2023, 52(8): 2688-271
Z-His-OBzl 是一种组氨酸衍生物,可介导Mn2+的配位共组装,形成基于肽的光敏纳米药物[1]。由于具有两亲性和正电荷特性,Z-His-OBzl可作为模板氨基酸衍生物,诱导近红外花菁染料indocyanine green (ICG)共组装[2]。Z-His-OBzl可调控phthalocyanine tetrasulfonic acid (Pc)自组装形成无囊泡结构的纳米颗粒,并在溶液中表现出荧光猝灭[3]。Z-His-OBzl可与内源性生物色biliverdin (BV)结合,制备具有宽近红外吸收的纳米颗粒,这些纳米颗粒可作为光声成像(PAI)造影剂,用于高空间分辨率和穿透深度的肿瘤诊断[4]。
| Cas No. | 20794-07-4 | SDF | |
| 分子式 | C21H21N3O4 | 分子量 | 379.42 |
| 溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6356 mL | 13.178 mL | 26.356 mL |
| 5 mM | 527.1 μL | 2.6356 mL | 5.2712 mL |
| 10 mM | 263.6 μL | 1.3178 mL | 2.6356 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















